Multiple sclerosis primary prevention: Difference between revisions
No edit summary |
|||
| Line 16: | Line 16: | ||
==== Early exposure to infections ==== | ==== Early exposure to infections ==== | ||
[[EBV infection]] in childhood is not a sever disease but in adults can presents as [[infectious mononucleosis]]. The similarity between the prevalence of [[infectious mononucleosis]] and [[MS]] point out that infection with this [[EBV|virus]] in childhood can reduce the risk of [[MS]] in comparison with adulthood infection. | |||
==References== | ==References== | ||
Revision as of 21:36, 3 March 2018
|
Multiple sclerosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Multiple sclerosis primary prevention On the Web |
|
American Roentgen Ray Society Images of Multiple sclerosis primary prevention |
|
Risk calculators and risk factors for Multiple sclerosis primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Primary Prevention
Effective measures for the primary prevention of multiple sclerosis include:
Vitamin D supplement
There is some evidence demonstrating that 1000 to 4000 IU vitamin D supplement daily can reduce the incidence of multiple sclerosis.[1][2][3]
Smoking cessation
Smoking cessation proved to be beneficial in reducing the incidence of MS disease.[4]
Early exposure to infections
EBV infection in childhood is not a sever disease but in adults can presents as infectious mononucleosis. The similarity between the prevalence of infectious mononucleosis and MS point out that infection with this virus in childhood can reduce the risk of MS in comparison with adulthood infection.
References
- ↑ Hollis BW (February 2005). "Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D". J. Nutr. 135 (2): 317–22. PMID 15671234.
- ↑ Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R (July 2005). "Estimates of optimal vitamin D status". Osteoporos Int. 16 (7): 713–6. doi:10.1007/s00198-005-1867-7. PMID 15776217.
- ↑ Vieth R (May 1999). "Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety". Am. J. Clin. Nutr. 69 (5): 842–56. PMID 10232622.
- ↑ Hernán MA, Olek MJ, Ascherio A (July 2001). "Cigarette smoking and incidence of multiple sclerosis". Am. J. Epidemiol. 154 (1): 69–74. PMID 11427406.